• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number NV UNK PIPELINE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intracranial Hemorrhage (1891); Rupture (2208); Unspecified Nervous System Problem (4426); Thrombosis/Thrombus (4440)
Event Date 03/01/2006
Event Type  Injury  
Manufacturer Narrative
Lylyk i, scrivano e, lundquist j, ferrario a, bleise c, perez n, lylyk pn, viso r, nella-castro r, lylyk p.Pipeline embolization devices for the treatment of intracranial aneurysms, single-center registry: long-term angiographic and clinical outcomes from 1000 aneurysms.Neurosurgery online.September 2021.Doi: cns.Org/spotlight.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Lylyk i, scrivano e, lundquist j, ferrario a, bleise c, perez n, lylyk pn, viso r, nella-castro r, lylyk p.Pipeline embolization devices for the treatment of intracranial aneurysms, single-center registry: long-term angiographic and clinical outcomes from 1000 aneurysms.Neurosurgery online.September 2021.Doi: cns.Org/spotlight.Medtronic literature review found reported of incomplete wall apposition and wire perforation in association with pipeline embolization.The purpose of this article was to investigate long-term outcomes from the pipeline embolization devices for the treatment of intracranial aneurysms (pedestrian) registry.The authors reviewed 835 patients (march 2006 to july 2019) with complex ias treated with ped.Patients with unfavorable anatomy and/or recurrence following previous treatment were included and excluded those with acute subarachnoid hemorrhage.Of the 835 patients, the average age was 55.9 years, 671 were female and 164 were male.In total, 1214 peds were deployed, with a single device in 84.2% (842/1000) and =2 devices in 95.8% (958/1000) of cases.Adjunctive coiling was performed in 9.3% (93/1000).Intraoperative technical complications occurred in 4.8% (48/1000) of treated aneurysms, with incomplete wall apposition of the device requiring balloon angioplasty representing the majority of technical complications (3.3% [33/1000]).Stroke-related complications occurred in 3.6% (30/835) of patients, the majority of which were caused by in-stent thrombosis (2.5% [21/835]).Nine deaths occurred due to stroke.They found a trend towards lower rates of thromboembolic complications since the implementation of prasugrel, with 26 (4.4%) patients on clopidogrel developing stroke compared with 4 (1.6%) patients on prasugrel.Hemorrhagic complications occurred in 1.8% (15/835) of patients, resulting in 11 deaths.The overall morbidity rate, including from subarachnoid hemorrhage, was 2.7% (23/835).The all-cause mortality rate was 4.6% (38/835), with a neurological mortality rate of 3.1% (26/835).The following intra- or post-procedural outcomes were noted: incomplete wall apposition requiring balloon angioplasty.Wire perforation.Distal thrombosis/embolism 4 stroke, in stent thrombosis.Hemorrhage, aneurysm rupture.Intraparenchymal hemorrhage.Neurological mortality.Mortality.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13217876
MDR Text Key286156440
Report Number2029214-2022-00030
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNV UNK PIPELINE
Device Catalogue NumberNV UNK PIPELINE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/20/2021
Initial Date FDA Received01/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age56 YR
Patient SexFemale
-
-